coplug
    Back to PCN explorer
    PCN reports · Core20PLUS5

    Mpa PCN, Medway (LAD) · Health Inequalities Profile

    PCN U12550 · NHS Kent and Medway Integrated Care Board · 2 GP practices

    Read the report

    This report is generated by Coplug's Healthcare Agent. Log in to ask further questions of it, add the spatial context, or create new enquiries to better understand and improve your Neighbourhood's Health

    01 / 15

    Board summary

    Key figures

    39,315

    Registered population

    63.5% aged 18–64

    11.2%

    Aged 65+

    ICB 19.9% · England 17.9%

    17.1%

    Ethnic minority (non-White)

    6.2% Asian · England 9.6%

    29.4%

    In IMD quintile 1

    ICB 17.1% · England 21.0%

    ~11,056

    Core20 residents (est.)

    Resident basis; registered basis ~11,624 · see page 3

    4,646

    Hypertension register

    +8.04% in 3 yrs · England +5.60%

    379

    SMI register

    13.3% of Medway (LAD)'s

    563

    COPD register

    Reviews -6.76% in 3 yrs

    Forecast to 2030

    6,211

    Hypertension patients, 2030

    +1,565 on today

    78.6%

    QRISK ≥20% on statins, 2030

    +5.22pp over 3 yrs

    3.4%

    Cancer prevalence, 2030

    England 4.5%

    Three things the board should see

    66.4%
    Age-five MMR2 uptake lags target by 28.6 pp.

    Age-5 MMR2 coverage is 66.4% (England 82.8%), with a 25.2 pp dose drop at Princes Park Medical Ctr versus 8.3 pp at Maidstone Road.

    59.2%
    Asthma review coverage falls behind England.

    Asthma annual review coverage is 59.2% (England 65.7%) after falling 4.6% over three years (England +4.4%), leaving about 750 patients without a recorded review.

    +23.1%
    Rapid three-year gains in diabetes and heart failure.

    Non-frail diabetes HbA1c control rose +23.1% (England +4.4%) to 48.0% (England 57.4%), while heart failure functional reviews rose +69.9% (England +8.7%).

    Sources & context

    PCN and practice-level primary care data; ICB and provider context on page 8

    Powered by Coplug · Page 1 of 15
    02 / 15

    Population, age and ethnicity

    Aged 0-17 patients reach 25.3%, exceeding Medway, ICB, and England proportions

    Across 39,315 registered patients, MPA PCN has a younger profile: 25.3% (9,962 patients) are aged 0-17, exceeding Medway (21.6%), NHS Kent and Medway ICB (20.7%), and England (19.6%). Patients aged 65+ comprise 11.2% (4,391), below Medway (17.9%), the ICB (19.9%), and England (17.9%). Princes Park Medical Ctr has 26.1% aged 0-17, whereas Maidstone Road Surgery has 15.5% aged 65+. Census resident figures show an 82.9% White share (Medway 84.3%, ICB 88.6%, England 81.1%) and a 17.1% ethnic minority share, though resident data does not record registered-patient ethnicity.

    Age profile

    0–1725.3%
    18–6463.5%
    65+11.2%

    65+: ICB 19.9%, England 17.9%

    Ethnicity

    White82.9%
    Black6.4%
    Asian6.2%
    Mixed3.0%
    Other1.4%

    Older people · falls rows are Medway (LAD) local-authority (LA) data, not PCN

    MeasureLocalSouth EastEnglandPeriod
    Falls admissions, 65+, per 100,000 (Medway LA)1,5072,0181,9582024/25
    Diabetes with frailty: HbA1c ≤75 mmol/mol (PCN)74.3%82.2%81.9%2024/25
    Diabetes without frailty: HbA1c ≤58 mmol/mol (PCN)48.0%57.8%57.4%2024/25
    Falls admissions, 65 to 79, per 100,000 (Medway LA)7409819552024/25
    Falls deaths, all ages, per 100,000 (Medway LA)19.514.014.82022‑24
    Sources & context

    Census 2021; Fingertips falls and diabetes. Falls are local-authority data. Ethnic minority = 100% minus White

    Powered by Coplug · Page 2 of 15
    03 / 15

    Deprivation and Core20

    Core20 deprivation reaches 29.4% of patients, concentrated at Princes Park Medical Ctr

    Across MPA PCN, 29.4% of registered patients live in Core20 communities, above Medway (23.1%), NHS Kent and Medway ICB (17.1%) and England (21.0%), with an average IMD decile of 4.3 (Medway 4.9, ICB 5.4, England 5.5). Modelled weighted practice shares (29.6%) show a 0.19 pp reconciliation gap against the PCN rate. Core20 concentration reaches 33.7% at Princes Park Medical Ctr (an estimated 10,281 patients) versus 15.3% at Maidstone Road Surgery (an estimated 1,343 patients), an 18.4 pp spread. Clinical and proactive outreach capacity should focus on Princes Park Medical Ctr.

    % of patients in IMD quintile 1, by practice

    Dashed line: England 21.0% · right column: Core20 patients, registered basis

    Princes Park33.7% · 10,281 patients
    Maidstone Road15.3% · 1,343 patients
    Sources & context

    Deprivation: Index of Multiple Deprivation, applied to registered patients

    Powered by Coplug · Page 3 of 15
    04 / 15

    PLUS groups and inclusion health

    PLUS groups and inclusion health

    379

    SMI register

    0.98% recorded prevalence

    379

    Learning disability register

    0.98% recorded prevalence

    47

    Care homes, 1,267 beds

    In the PCN catchment

    8.9%

    Provide unpaid care

    Medway (LAD), Census 2021

    The PCN records 379 patients on the learning disability register (1.0%), above Medway (0.7%), NHS Kent and Medway ICB (0.6%), and England (0.6%), alongside 379 severe mental illness patients (1.0%; England 1.0%). Catchment data shows 47 care homes with 1,267 beds, which does not confirm resident patient numbers. Learning disability prevalence exceeds all benchmarks, so completing tailored annual health checks is the priority workload to protect.

    Severe mental illness: physical health checks

    Annual BMI recording for severe mental illness patients fell 10.0 pp over 2023 to 2025 (England +5.1 pp) to 78.5% (England 82.1%), while blood pressure checks rose 8.6 pp (England +4.4 pp) to 76.7% (England 83.4%).

    Sources & context

    QOF registers; Census 2021 carers; care homes and homelessness as supplied. Carers and homelessness are local-authority data

    Powered by Coplug · Page 4 of 15
    05 / 15

    Clinical focus: hypertension and lipids

    Clinical focus: hypertension and lipids

    4,646

    Hypertension register

    +8.04%

    Register growth, 3 yrs

    Medway (LAD) +3.74% · England +5.60%

    +4.60pp

    BP control, under 80

    ≤140/90 · +5.91pp aged 80+

    +1,565

    More patients by 2030

    Forecast 6,211 (13.97%)

    Hypertension case-finding and control

    Hypertension prevalence is 12.0% (4,646 patients), below Medway (15.4%) and England (15.2%), giving an unadjusted scenario gap of +1,342 to +1,428 patients that may be an upper bound given the younger population (11.2% aged 65+ vs 17.9% in England). While under-80 blood pressure control rose +8.0% over 2023 to 2025 (England +3.2%), current control is 62.1% against 67.8% in England, with Princes Park Medical Ctr at 60.0% and Maidstone Road Surgery at 68.0%. Lagging blood pressure control among patients under 80 leaves an identifiable gap against national benchmarks, indicating that titration and recall could be prioritised at Princes Park Medical Ctr.

    Lipids and statins

    Uptake of lipid-modifying therapy in high-risk patients (QRISK ≥ 20%) is 66.8%, exceeding Medway (64.0%) and England (63.6%). In CKD, coverage reaches 72.9% (England 70.3%). Higher coverage than national benchmarks indicates that sustaining treatment adherence across high-risk primary prevention cohorts remains the clinical priority.

    MeasureItemsCost / itemICBEnglandAnnual spend
    Lipid-modifying, 202650,000£2.30£1.90£1.86£115,000
    Cardiovascular (all), 202562,046£3.01£3.57£3.33£186,758

    In 2026, the PCN prescribed 50,000 lipid-modifying items at £2.30 per item, compared to £1.86 in England, £1.87 in Medway, and £1.90 across the ICB, spending £22,000 more than at England's unit cost. Spending more per item than England points to an opportunity for clinical pharmacists to review lipid-modifying prescribing choices.

    Sources & context

    QOF hypertension register and BP control indicators; prescribing items and cost as supplied

    Powered by Coplug · Page 5 of 15
    06 / 15

    Clinical focus: respiratory, cancer register and children

    Clinical focus: respiratory, cancer register and children

    Respiratory

    −4.61%

    Asthma reviews, PCN 3-yr % change

    +4.44%

    Asthma reviews, England 3-yr % change

    −0.31%

    Asthma prevalence, PCN 3-yr % change

    Asthma annual review coverage is 59.2% (Medway 62.6%, England 65.7%), following a 4.6% decline over 2023 to 2025 (England +4.4%), leaving about 750 patients unreviewed. COPD reviews fell 6.8% over 2023 to 2025 (England +2.8%) to 75.1% (England 76.4%), while COPD prevalence fell 12.0% (England +2.6%) to 1.4% (England 1.9%). Asthma management items prescribed for ages 5-19 stand at 1,062 per 1,000 (England 1,488).

    Cancer register and children's immunisation

    Cancer register prevalence is 2.7% (England 3.8%). In Q1 2025/26, age-5 MMR dose 2 and 4-in-1 coverage are both 66.4%, below the 95.0% target by 28.6 pp (England 82.8% and 80.9%). The PCN MMR first-to-second dose drop is 21 pp (from 87.4%), reaching 25.2 pp at Princes Park Medical Ctr against 8.3 pp at Maidstone Road Surgery.

    Dashed line: 95% national coverage target · solid tick: England

    6-in-1 at 12 months94.4%

    England 91.0%

    6-in-1 complete primary course at 24 months92.9%

    England 92.2%

    MMR dose 1 at 24 months91.3%

    England 88.3%

    MMR dose 2 at age 566.4%

    England 82.8%

    4-in-1 pre-school booster at age 566.4%

    England 80.9%

    Sources & context

    QOF registers and review indicators; childhood immunisation coverage as supplied

    Powered by Coplug · Page 6 of 15
    07 / 15

    Early cancer diagnosis

    Early cancer diagnosis

    55.6%

    Kent and Medway ICB, stage 1–2

    55.3%

    England, 2022

    75%

    National ambition by 2028

    ~1,630

    Extra early-stage cases a year to reach the ambition

    Stage 1–2 share by cancer type, 2022Kent and Medway ICBEnglandNo usable stageStaged cancers
    Breast82.1%85.4%23%1,509
    Prostate54.4%53.2%37%1,435
    Lung29.4%33.8%21%1,109
    Bowel48.2%47.0%29%1,013
    Skin cancer87.5%87.8%23%562

    In 2022 across NHS Kent and Medway ICB, 55.6% of staged cancers were diagnosed at stage 1 or 2 (4,661 of 8,384 staged cancers; distance -19.4 pp to the 75.0% national ambition; England 55.3%), with known stage recorded for 63.6% of 13,189 registrations; reaching the ambition requires about 1,630 extra early diagnoses annually. At PCN level, cervical screening uptake is 62.8% (Medway LAD 71.5%, England 66.8%) and breast screening coverage is 62.3% (Medway LAD 69.2%, England 69.9%). Princes Park Medical Ctr records 61.2% in cervical screening, while Maidstone Road Surgery records 69.0%. Crude cancer prevalence is 2.7% (1,059 patients; England 3.8%), which is not age-adjusted.

    Sources & context

    Stage at diagnosis: National Disease Registration Service

    Powered by Coplug · Page 7 of 15
    08 / 15

    Cancer waits, diagnostics and community services

    Cancer waits, diagnostics and community services

    Cancer waits and diagnostics, Jul 2026 (provisional)

    In July 2026, Medway NHS Foundation Trust achieved 81.6% against the 85.0% cancer 62-day standard (distance -3.4 pp; ICB 75.9%, England 71.2%, Maidstone and Tunbridge Wells NHS Trust 87.4%). It met the 28-day faster diagnosis standard at 77.8% (standard 75.0%; ICB 76.8%, England 79.3%) and the 31-day standard at 99.6% (standard 96.0%). For diagnostics, 14.2% of patients waited 6+ weeks across all diagnostic tests (England 23.1%, Maidstone and Tunbridge Wells NHS Trust 6.4%), including 1.9% for colonoscopy (England 30.8%) but 36.6% for echocardiography (England 28.5%). These provider figures describe system access, not PCN performance.

    Pathways within standard (%)MedwayMaidstone and Tunbridge WellsMid and South EssexKent and Medway ICBEngland
    28-day faster diagnosis (75%)77.7781.7867.4576.7879.32
    31-day treatment (96%)99.6298.3581.8895.8492.50
    62-day referral to treatment (85%)81.6487.4350.2575.9371.16
    Diagnostic waits over 6 weeks (%)MedwayMaidstone and Tunbridge WellsMid and South EssexEngland
    MRI0.680.9223.3521.40
    CT0.000.516.079.92
    Echocardiography36.622.5765.0528.48
    Colonoscopy1.8819.8064.0930.83
    Gastroscopy3.3224.0359.7629.02
    All 15 DM01 tests14.206.4241.5423.14
    Community services activityMedway residentsKent and Medway ICB
    Care contacts43,510254,055
    Referrals8,58068,085
    Patients with a contact11,54072,060

    Community services (residents of Medway), Jun 2026 (provisional). In June 2026, provisional community services records showed 43,510 care contacts across 11,540 Medway residents, with 8,580 referrals and 31,250 care activities; adults aged 65+ accounted for 62% of contacts (26,985). Across NHS Kent and Medway ICB, contacts totaled 254,055 across 72,060 patients, with 68,085 referrals. These experimental provider submissions reflect wider system community activity rather than exclusive PCN caseloads.

    Sources & context

    Waits and diagnostics: NHS England monthly statistics · ICB and provider data, not PCN

    Powered by Coplug · Page 8 of 15
    09 / 15

    Practice variation and patient experience

    Phone access is 31.8% to 34.6% across practices, trailing England's 56.9% benchmark

    In 2025/26, QOF clinical-domain achievement was 97.9% at Maidstone Road Surgery and 96.4% at Princes Park Medical Ctr (England 97.1%). In the vaccination and immunisation domain, achievement was 24.8% and 18.5% respectively (England 55.2%, a 6.3 pp spread). Personalised care adjustment rates across all domains were 12.6% at Maidstone Road Surgery and 14.3% at Princes Park Medical Ctr (England 10.0%).

    GP Patient Survey by practice

    PracticeResponses% in IMD Q1Phone easyRequest led to apptOverall good
    Princes Park13633.731.8%48.0%53.6%
    Maidstone Road10015.334.6%56.3%52.4%
    England—~2156.9%71.6%76.7%
    Sources & context

    QOF achievement; GP Patient Survey, practice-level results

    Powered by Coplug · Page 9 of 15
    11 / 15

    What the data can't tell us: gaps and local assets

    What the data can't tell us: gaps and local assets

    Local assets and voluntary sectorPCNMedway (LAD)AssetPCNMedway (LAD)
    Care homes (catchment)47 (1,267 beds)n/aSchools (catchment)114n/a
    Children's centres819Places of worship56110
    Libraries39Food banks (VCS)26
    Homelessness support (VCS)19Day centres (VCS)829
    Children and young people (VCS)2965Carers support groups (VCS)1022
    Primary schools (LA maintained)917Primary academies2756

    0 = the source returned zero. n/a = not held at this level. No data = no value returned; this does not mean zero.

    Sources & context

    Gaps are modelled estimates against benchmark rates; local assets as supplied

    Powered by Coplug · Page 11 of 15
    12 / 15

    Options for the PCN

    Options for the PCN

    Each option in full

    Option 1

    Age-five immunisation recall in Core20

    Age-5 MMR2 and 4-in-1 coverage are both 66.4% in Q1 2025/26 (cohort 143; England 82.8% and 80.9%), below the 95.0% target by 28.6 pp, with a 21 pp drop from MMR1 (87.4%). For discussion, audit age-5 call-recall lists, verify contact details for non-responders, and test flexible pre-school vaccination slots. Moderate effort to run.

    Evidence base: coverage against the 95% target is the direct measure of programme delivery and catch-up need; where coverage clusters low, that decides whether catch-up is organised at practice, PCN, school or outreach level.

    Policy anchor: 10 Year Health Plan, shift from sickness to prevention.

    Option 2

    Structured asthma and COPD review recall

    Asthma reviews are 59.2% (England 65.7%, Medway 62.6%), leaving 751 (about 750) of 1,843 patients unreviewed; COPD reviews fell 6.8% over 2023 to 2025 (England +2.8%) to 75.1%. For discussion, practices could run a single respiratory recall template, align inhaler checks with annual reviews, and offer flexible slots. Moderate effort to run.

    Evidence base: the annual asthma review is the process gap between the register and outcomes.

    Policy anchor: Core20PLUS5 chronic respiratory disease priority.

    Option 3

    Hypertension case-finding and under-80 BP titration

    Under-80 BP control is 62.1% (England 67.8%, Medway 65.3%; Princes Park Medical Ctr 60.0%). Hypertension prevalence is 12.0% (4,646 patients; England 15.2%, Medway 15.4%), an unadjusted gap of +1,342 to +1,428. Moderate effort to run.

    Evidence base: the hypertension register is the cohort for case-finding, blood-pressure control and AF anticoagulation; its size and growth set the workload those interventions must cover, and a shortfall in control shows up later as emergency admission.

    Policy anchor: Core20PLUS5 (hypertension case-finding and optimal management); NHS CVD ambitions to 2029 on detection, treatment to target and statins for high-risk patients (CVDPREVENT).

    Sources & context

    Options are the profile's; evidence base from Coplug's indicator catalogue

    Powered by Coplug · Page 12 of 15
    13 / 15

    Provenance and audit trail

    Provenance and audit trail

    Figures are the profile's, drawn from Coplug indicator tables: census, deprivation and QOF measures, MHCLG, Rough sleeping snapshot in England: autumn 2025, OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) and OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002). Every recommended action and option is the profile's own; the evidence-base statements that support them — what each register is the cohort for, and the national policy it serves — are quoted from Coplug's indicator catalogue. No recommendation in this report is authored outside the profile and that catalogue. ICB- and provider-level data (page 8) describes the system the PCN sits in and is not read as PCN performance.

    RecommendationIndicator(s)Policy anchorData level
    Paediatric capacity and outreach planning (p2)Aged 0-17Medium Term Planning Framework 2026 · Neighbourhood health frameworkPCN
    Targeted Core20 proactive outreach (p3)Core20 cohort (IMD quintile 1)Core20PLUS5 · 10YHP equity testPCN
    SMI cardiometabolic check review (p4)Record of BMI in the last 12 months for patients on the MH register (denominator incl. PCAs)MHIS · From Harm to HopePCN
    Hypertension control review (p5)Last BP reading of patients (<80 yrs with hypertension) in the last 12 months is <= 140/90 mmHg (denominator incl. PCAs)Core20PLUS5 CVD · CVDPREVENT 2029PCN
    Pre-school immunisation recall audit (p6)MMR dose 2 coverage at age 510YHP sickness to prevention · 95% targetPCN
    Cervical screening recall audit (p7)Women (25-49 yrs) with a record of cervical screening in the last 3.5 yrs (denominator incl. PCAs)Fit for the Future: 10 Year Health Plan for England · Medium Term Planning Framework 2026PCN
    Telephony and digital triage review (p9)GPPS easy to contact the practice by phone10YHP, hospital to communityPractice
    Option 1 · Age-five immunisation recall in Core20 (p12)MMR dose 1 coverage at age 5 · MMR dose 2 coverage at age 5 · 4-in-1 pre-school booster (DTaP/IPV) coverage at age 510YHP sickness to prevention · 95% target · Core20PLUS5 · 10YHP equity testPCN & Practice
    Option 2 · Structured asthma and COPD review recall (p12)Asthma register · Patients with Asthma: review in the last 12 months (denominator incl. PCAs) · COPD registerCore20PLUS5 respiratoryPCN & Practice
    Option 3 · Hypertension case-finding and under-80 BP titration (p12)Hypertension register · Hypertension: QOF prevalence · Registered populationCore20PLUS5 CVD · CVDPREVENT 2029PCN & Practice
    Sources & context

    Re-run this profile in 12 months to see whether the gaps have narrowed

    Powered by Coplug · Page 13 of 15
    14 / 15

    Data sources

    Data sources

    Every figure in this profile comes from a dataset below, at the level and period stated. Nothing published above PCN level is read as PCN performance.

    DatasetLevelPeriodUsed for
    Coplug indicator tables: census, deprivation and QOF measuresPCN & Practice2023 to 2025, projected to 2030; 2023 to 2024Pages 1, 2, 3, 4, 5, 6, 7, 8, 10, 12
    MHCLG, Rough sleeping snapshot in England: autumn 2025Local authorityAutumn 2025Pages 2, 4
    OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713)PCN2024/25Pages 2, 4
    OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002)Local authority2024/25; 2022-24Pages 2, 4
    ONS, Census 2021 TS039: provision of unpaid care (age-standardised)Local authorityCensus 2021Pages 2, 4
    QOF registers, prevalence and care processes (Coplug indicator tables)Practice2023 to 2025, projected to 2030Pages 4, 5, 6, 7, 8, 10
    UKHSA, COVER supplementary GP data, childhood immunisation coverage, Q1 2025/26PCN & PracticeQ1 2025/26Pages 4, 6
    UKHSA, Seasonal influenza vaccine uptake in GP patients, 2025 to 2026Local authority2025/26 season to 28 Feb 2026Pages 4, 6
    NHS England, Cancer Waiting Times: July 2026 monthly time series with revisionsICB & ProviderJul 2026 (provisional)Pages 7, 8
    NHS England, Community Services Statistics (CSDS): June 2026 provisional experimental dataICB & Local authorityJun 2026 (provisional)Pages 7, 8
    NHS England, Monthly Diagnostics Waiting Times and Activity (DM01): provider by test, July 2026ProviderJul 2026Pages 7, 8
    National Disease Registration Service, Stage at diagnosis by cancer site in England, 2013 to 2022ICB2022Pages 7, 8
    NHS England / Ipsos, GP Patient Survey 2026: practice results (weighted)PracticeSurvey Jan-Apr 2026Page 9
    NHS England, Quality and Outcomes Framework 2025-26: achievement by practice and domainPractice2025/26Page 9
    NHS England, Quality and Outcomes Framework 2025-26: personalised care adjustments by practice and domainPractice2025/26Page 9
    Coplug indicator catalogue — definitions, cohorts, policy anchorsReferenceCurrentEvidence-base lines, page 13
    Sources & context

    Where a period is given as "as supplied", the source file did not state a vintage

    Powered by Coplug · Page 14 of 15
    15 / 15

    Methods, data-quality notes and limitations

    Methods, data-quality notes and limitations

    Methods

    Estimated gaps apply benchmark prevalence to the registered population and subtract the recorded register. They size the task; they are not confirmed missed patients.

    Percentage points are the difference between two rates; a relative change is that difference as a share of the starting rate. Register changes are relative, over three years.

    Forecasts to 2030 extend each indicator's current trajectory with no change in case-finding or service model: a baseline to act against, not a prediction.

    Core20 is the most deprived 20% nationally (IMD quintile 1). Practice shares are not additive to the PCN figure. Ethnic minority is 100% minus White. Local-authority averages are unweighted.

    Sources & context

    Estimates size the task; they are not confirmed missed patients

    Powered by Coplug · Page 15 of 15